Quarterly earnings report displays a comparative analysis of EPS and revenue between the current and previous quarters, along with percentage changes.
Quarter | EPS (Earnings Per Share) | Revenue |
---|---|---|
Q2 - 2024 | 1.05 (-11.76%) ▼ | $1,573,000,000 (-5.13%) ▼ |
Q1 - 2024 | 1.19 (-26.99%) ▼ | $1,658,000,000 (-1.78%) ▼ |
Q4 - 2023 | 1.63 (328.95%) ▲ | $1,688,000,000 (0.96%) ▲ |
Q3 - 2023 | 0.38 (-62.75%) ▼ | $1,672,000,000 (-2.62%) ▼ |
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
The Stock Analysis section offers a comprehensive ranking-based analysis alongside its peer stocks, aiding in the identification of potential future growth for the stock.
The Analyst Forecasts section displays Wall Street analysts' predictions for stock price growth or decline in the next 12 months.
In the Technical Analysis section for this stock, various timeframes, moving averages, and technical indicators offer insights into sentiment trends, helping forecast whether the prevailing sentiment suggests a buy or sell recommendation.
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
A, CAR and BGS have been added to the Zacks Rank #5 (Strong Sell) List on June 7, 2024....
Agilent (A) boosts its presence in the mass spectrometry market with the launch of the Agilent 7010D Triple Quadrupole GC/MS System and the Agilent ExD Cell....
Agilent Technologies, Inc. (NYSE:A ) Jefferies 2024 Global Healthcare Conference June 5, 2024 8:30 AM ET Company Participants Robert McMahon - Senior Vice President and Chief Financial Officer Confere...
San Francisco, California--(Newsfile Corp. - June 4, 2024) - ePrep is delighted to announce a new partnership with Agilent - a global leader in technology platforms for analytical laboratories - for...
Examine the evolution of Agilent's (A) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects....
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc., (NYSE: A) is introducing two new products at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics. The Agilent 7010D Triple ...
BOSTON--(BUSINESS WIRE)--The following closed-end funds reported sources of distribution for May and this fiscal year to date. Distribution Period: May 2024 Ticker Tax-Exempt Funds Distribution Amo...
Agilent's (A) fiscal second-quarter results reflect weak momentum across all end markets....
Agilent Technologies, Inc. (NYSE:A ) Q2 2024 Results Conference Call May 29, 2024 4:30 PM ET Company Participants Parmeet Ahuja - Investor Relations Padraig McDonnell - President & Chief Executive Off...
While the top- and bottom-line numbers for Agilent (A) give a sense of how the business performed in the quarter ended April 2024, it could be worth looking at how some of its key metrics compare to W...
Agilent Technologies (A) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.27 per share a year ago....
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.57 billion for the second quarter ended April 30, 2024, a decline of 8.4% reported and 7.4...
Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.